The clinical and biochemical parameters in relation to the serum neopterin levels in Indian children and adolescents

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 4, 2013, Pages 618-621

  Srinivasa Nageswara Rao, G ^a   Gurumurthy, Prema ^b   Sruti, E ^a   Cherian, K M ^b  

^a TN Dr MGR Medical University   (India)

^b International Centre for Cardio Thoracic and Vascular Diseases   (India)

Author keywords

Children; HPLC; Neopterin; Obesity

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NEOPTERIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BODY MASS; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIA; INSULIN BLOOD LEVEL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NEOPTERIN BLOOD LEVEL; PATHOGENESIS; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

EID: 84875896688     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5128.2866     Document Type: Article

References (23)

1. Krassas GE, Tzotzas T. Do obese children become obese adults: childhood predictors of adult disease. Paediatr Endocrinol Rev. 2004; 3:455-459.
2. Hansson GK. Mechanisms of disease:inflammation, atherosclerosis and coronary artery disease". N Engl J Med. 2005;352(16):1685-1626.
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Atherosclerosis. 2002;105:1135-43.
4. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation and insulin resistance. Eur cytokine Net w. 2006;17:4-12.
5. Ledochowski M, Murr C, Widner B, Fuchs D."Association between insulin resistance, body mass and neopterin concentrations" Clinica Chimica Acta. 1999;282:115-123.
6. Vengen IT, Dale AC, Wiseth R, Midthjell K, Videm V. "Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus. Long term follow up of the HUNT 1 Study. Atherosclerosis. 2009; 207(1):239-244.
7. Tatzber F, Rabl H, Koriska K, Erhart U, Puhl H, Waeg G et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 1991;89:203-208.
8. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation associated production of neopterin derivatives in humans. Inflamm Res. 2003;52:313-321.
9. Gieseg SP, Crone EM, Flavall EA, Amit Z. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydro neopterin synthesis. Br J Pharmacol. 2008;153:627-635.
10. Palfrey SM, Labib MH. A simple method for measuring neopterin in serum using HPLC. Ann Clin Biochem. 1993;30(2):209-210.
11. Fuchs D, Avanzas P, Arroyo Espliguero R, Jenny M, Consuegra- Sanchez L, Kaski JC. The role of neopterin in atherogenesis and cardiovascular risk assessment. Current Medicinal Chemistry. 2009; 16(35):4644-4653.
12. Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis. 1994;106(2):263-271.
13. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxy nitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res. 2000;87:241-247.
14. Manage H, Freytag F, Almer G, Weghuber D, Denk CB, Fuchs D. Serum neopterin is not increased in obese juveniles. J Obesity. 2011;2011:1-7.
15. Ursavasx A, Karadag M, Oral AY, Demirdogen E, Oral HB, Ege E. Association between serum neopterin, obesity and day time sleepiness in patients with obstructive sleep apnea. Respiratory Medicine. 2008;102:1193-1197.
16. Bozdemir AE, Barutcuoglu B, Dereli D, Kabaroglu C, Habif S, Bayindir O. C-reactive protein and neopterin levels in healthy non obese adults. Clin Chem Lab Med. 2006;44(3):317-321.
17. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Quiles J, Zouridakis E, Kaski JC. Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Am J Cardiol. 2004;93(5):627-629.
18. Singh B, Saxena A. Surrogate markers of insulin resistance: A review. World J Diabetes. 2010;1(2):36-47.
19. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation. 2003;107:1448-1453.
20. Keskin M, Selim Kurtoglu M, Kendirci M, Atabek E, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:500-503.
21. Plata-Nazar K, Luczak G, Borkowska A, Delinska-Galinska A, Kozieiska E, Marek K et al. Reference standard of serum neopterin concentration in healthy children. Pteridines. 2007; 18:19-24.
22. Satoh T, Brown L, Blattner WA, Maloney EM, Kurman CC, Nelson DL et al. Serum neopterin, β-2-microglobulin, soluble interleukin-2 receptors and immunoglobulin levels in healthy adolescents. Clin Immunol Immunopatol. 1998;88:176-182.
23. Wardle J, Carnell S, Haworth CMA, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr. 2008;87:398-404.